Author

David Price

Observational and Pragmatic Research Institute, University of Aberdeen - Cited by 63,336 - asthma copd real-life opcrd

Biography

Dr David Price is Managing Director of Observational & Pragmatic Research Institute (Singapore) and Optimum Patient Care (Australia, Singapore and UK). He is Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen (Scotland). His area of interest lies in ‘real-life’ research. He has authored over 400 peer-reviewed publications and is responsible for approximately US$30 million in research and clinical development grants.
Title
Cited by
Year
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study
S Soremekun, LG Heaney, D Skinner, L Bulathsinhala, V Carter, ...Thorax 78 (7), 643-652, 2023202
15
2023
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
S Cotton, G Devereux, H Abbas, A Briggs, K Campbell, R Chaudhuri, ...Trials 23 (1), 1-16, 2022202
9
2022
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group
ER Bleecker, M Al-Ahmad, L Bjermer, M Caminati, GW Canonica, ...World Allergy Organization Journal 15 (12), 10026, 2022202
7
2022
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
H Heatley, TN Tran, A Bourdin, A Menzies-Gow, DJ Jackson, E Maslova, ...thorax, 2022202
4
2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study
A Menzies-Gow, M Gurnell, LG Heaney, J Corren, EH Bel, J Maspero, ...European Respiratory Journal 60 (6), 2022202
4
2022
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
C Jackson, ID Stewart, T Plekhanova, PS Cunningham, AL Hazel, ...The Lancet Respiratory Medicine, 20220
3
2023
Comparative effectiveness of Anti‐IL5 and Anti‐IgE biologic classes in patients with severe asthma eligible for both
PE Pfeffer, N Ali, R Murray, C Ulrik, TN Tran, J Maspero, M Peters, ...Allergy, 20220
3
2023
Understanding how context and culture in six communities can shape implementation of a complex intervention: a comparative case study
J Gaber, J Datta, R Clark, L Lamarche, F Parascandalo, S Di Pelino, ...BMC Health Services Research 22 (1), 1-1, 2022202
3
2022
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
EL Tomaszewski, MJ Atkinson, C Janson, N Karlsson, B Make, D Price, ...Respiratory Research 4 (1), 1-13, 030
2
2023
Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians …
JWH Kocks, H Cao, B Holzhauer, A Kaplan, JM FitzGerald, K Kostikas, ...The Journal of Allergy and Clinical Immunology: In Practice 11 (5), 1463 …, 030
2
2023
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
HJC McAuley, RA Evans, CE Bolton, CE Brightling, JD Chalmers, ...EClinicalMedicine 57, 030
2
2023
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK database study
ID Pavord, TN Tran, RC Jones, J Nuevo, M van den Berge, GG Brusselle, ...The Journal of Allergy and Clinical Immunology: In Practice 11 (), 53-543, 030
2
2023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Determinants of recovery from post-COVID-9 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-9 patients and community-based controlsB Zheng, G Vivaldi, L Daines, OC Leavy, M Richardson, O Elneima, ...The Lancet Regional Health–Europe, 2023202
1
2023
Health TAPESTRY Ontario: a multi-site Randomized Controlled Trial Testing implementation and reproducibility
D Mangin, L Lamarche, D Oliver, G Blackhouse, S Bomze, S Borhan, ...The Annals of Family Medicine 2 (2), 32-42, 2023202
1
2023
What have we learnt from real‐life research in asthma and COPD? Standards and novel designs for the future
D Price, T UthamanRespirology 27 (2), 08-02, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=o10PzG0AAAAJ

Cited by
Citations 63336
h-index 108
i10-index 485
Recommended Journals
Open Access Journals